Xtant Medical/$XTNT
1D1W1MYTD1Y5YMAX
Capital at risk
About Xtant Medical
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.
- Ticker
- $XTNT
- Sector
- Health
- Primary listing
- AMEX
- Employees
- 151
- Headquarters
- Belgrade, United States
- Website
- xtantmedical.com
Xtant Medical Metrics
BasicAdvanced
$53M
-
-$0.08
-0.14
-
Price and volume
Market cap
$53M
Beta
-0.14
52-week high
$0.95
52-week low
$0.27
Average daily volume
3.4M
Financial strength
Current ratio
2.162
Quick ratio
0.977
Long term debt to equity
24.201
Total debt to equity
65.006
Interest coverage (TTM)
-1.99%
Profitability
EBITDA (TTM)
-1.473
Gross margin (TTM)
59.39%
Net profit margin (TTM)
-10.17%
Operating margin (TTM)
-5.02%
Effective tax rate (TTM)
-20.54%
Revenue per employee (TTM)
$730,000
Management effectiveness
Return on assets (TTM)
-3.75%
Return on equity (TTM)
-25.16%
Valuation
Price to revenue (TTM)
0.479
Price to book
1.31
Price to tangible book (TTM)
1.56
Price to free cash flow (TTM)
-75.453
Free cash flow yield (TTM)
-1.33%
Free cash flow per share (TTM)
-0.005
Growth
Revenue change (TTM)
-14.28%
Earnings per share change (TTM)
109.04%
3-year revenue growth (CAGR)
17.27%
10-year revenue growth (CAGR)
2.89%
3-year earnings per share growth (CAGR)
-3.67%
10-year earnings per share growth (CAGR)
-34.39%
What the Analysts think about Xtant Medical
Analyst ratings (Buy, Hold, Sell) for Xtant Medical stock.
Analyst projections of the future price of Xtant Medical stock.
Xtant Medical Financial Performance
Revenues and expenses
Xtant Medical Earnings Performance
Company profitability
Upcoming events
No upcoming events
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.